Recruiting
End stage renal disease+1
RecruitingStudy of Patiromer to Allow Less Dietary Potassium Restrictions in Patients on Chronic Dialysis with Controlled Blood Potassium Levels
Registered drug
Study of Patiromer to Allow Less Dietary Potassium Restrictions in Patients on Chronic Dialysis with Controlled Blood Potassium Levels
Registered drug
- Disease:End stage renal diseaseDialysis
- Substances:Patiromer
Countries:
Italy
Italy- Participants:18–64 years · 65+ years
- Substances:Patiromer
- Sponsor:Istituto Di Ricerche Farmacologiche Mario Negri



